Our in vivo model of IRF8-mutant B cell lymphoma validated this initial observation and linked it to defective antigen loading into MHCII complexes because it could be rescued with CD74 ectopic expression. This evidence concerns the gene CD74 and B-cell non-Hodgkin lymphoma.